Skip to main content

Table 4 Comparison of ART outcomes after 1 year between those with one or more worries and those without any worry at the first eligibility assessment

From: Patients’ worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009

ART outcomes

Worries reported at assessment for ART eligibility

No worry

One worry or more

Specific worries

  

HIV status disclosure

Nutrition

Condoms use

Use of other medication

ART Adherence

ART side effects

n=104

n=195

n=54

n=38

n=23

n=26

n=19

n=19

Total with CD4 counts after ART eligibility

63

134

32

22

14

18

15

11

Mean CD4 counts increase (per year) (95% CI)

162

199

112

127

97

363

189

156

(112-211)

(129-270)

(80-145)

(87-167)

(42-151)

(-19-746)

(56-322)

(-31-343)

Median CD4 increase

92

114

73

112

74

122

115

168

(IQR)

(47-212)

(41-213)

(41-183)

(46-215)

(40-106)

(59-210)

(33-232)

(73-237)

Total with viral loads

54

126

33

24

14

16

15

12

CD4 count > 100 after ART start

42 (78%)

95 (75%)

23 (70%)

16 (67%)

10 (71%)

10 (63%)

15 (100%)

12 (100%)

Annual decrease in median log VL (IQR)

0.01

−0.10*

−0.24*

0.04*

0.18

0.17

−0.14

0.05

(-0.10-0.12)

(-0.19 - -0.02)

(-0.41 - -0.07)

(-0.12 - -0.21)

(0.01-0.35)

(0.12 - 0.33)

(-0.49 - 0.20)

(-0.02 - 0.30)

Number who started ART

104

195

51

38

23

24

19

19

Substituted / switched ART

29 (28%)

53 (27%)

16 (31%)

7 (18%)

6 (26%)

8 (33%)

3 (16%)

7 (37%)

Died

19 (18%)

13 (7%)

5 (10%)

4 (11%)

1 (4%)

1 (4%)

0 (0)

1 (5%)

  1. *p<0.05 Note: Comparisons are between those with one or more worries and those with no worry, and also between those with a particular worry and all those without that particular worry.